Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Retrograde nerve growth factor signaling abnormalities in familial dysautonomia
Lin Li, … , Katherine Gruner, Warren G. Tourtellotte
Lin Li, … , Katherine Gruner, Warren G. Tourtellotte
Published April 13, 2020
Citation Information: J Clin Invest. 2020;130(5):2478-2487. https://doi.org/10.1172/JCI130401.
View: Text | PDF
Research Article Cell biology Neuroscience

Retrograde nerve growth factor signaling abnormalities in familial dysautonomia

  • Text
  • PDF
Abstract

Familial dysautonomia (FD) is the most prevalent form of hereditary sensory and autonomic neuropathy (HSAN). In FD, a germline mutation in the Elp1 gene leads to Elp1 protein decrease that causes sympathetic neuron death and sympathetic nervous system dysfunction (dysautonomia). Elp1 is best known as a scaffolding protein within the nuclear hetero-hexameric transcriptional Elongator protein complex, but how it functions in sympathetic neuron survival is very poorly understood. Here, we identified a cytoplasmic function for Elp1 in sympathetic neurons that was essential for retrograde nerve growth factor (NGF) signaling and neuron target tissue innervation and survival. Elp1 was found to bind to internalized TrkA receptors in an NGF-dependent manner, where it was essential for maintaining TrkA receptor phosphorylation (activation) by regulating PTPN6 (Shp1) phosphatase activity within the signaling complex. In the absence of Elp1, Shp1 was hyperactivated, leading to premature TrkA receptor dephosphorylation, which resulted in retrograde signaling failure and neuron death. Inhibiting Shp1 phosphatase activity in the absence of Elp1 rescued NGF-dependent retrograde signaling, and in an animal model of FD it rescued abnormal sympathetic target tissue innervation. These results suggest that regulation of retrograde NGF signaling in sympathetic neurons by Elp1 may explain sympathetic neuron loss and physiologic dysautonomia in patients with FD.

Authors

Lin Li, Katherine Gruner, Warren G. Tourtellotte

×

Figure 1

Cytoplasmic Elp1 is essential for NGF-dependent retrograde sympathetic neuron survival.

Options: View larger image (or click on image) Download as PowerPoint
Cytoplasmic Elp1 is essential for NGF-dependent retrograde sympathetic n...
(A) Partitioned neuron cultures, which isolate cell bodies (CB) from distal axons (DA), were used to assess retrograde neuron survival when NGF was applied to the microfluidically isolated DA compartment using Bisbenzimide (Bis) to label nuclear DNA (green) and fluorescent microspheres (FS) to identify neurons that extended axons into the DA compartment and retrogradely transported them (red). Apoptotic neurons were identified by condensed, fragmented or absent nuclear DNA. Apoptotic cells not containing retrogradely transported FS (†) were not scored, but apoptotic FS-containing neurons (FS+, arrowhead) and healthy FS+ neurons with open chromatin and punctate nucleoli (arrow) were scored. Scale bar: 20 μM. (B) Whereas most neurons survived when 10 ng/mL NGF was present in the DA compartment in TCtl neurons, there is significantly less survival of TcKO neurons even when NGF was escalated 50-fold in the DA compartment (Student’s t test; *P = 0.007, n = 3–6; **P = 0.004, n = 4; ***P = 0.04, n = 3). (C) TcKO neurons differentiated in partitioned cultures and infected with doxycycline-inducible adenoviruses showed highly significant NGF-dependent survival abnormalities when only GFP was expressed in them (Student’s t test; *P < 0.0001, n = 7), and their retrograde survival was completely rescued when Elp1 expression was restored (n = 3). Expression of nuclear localized Elp1 (Elp1-nuc) showed highly significant retrograde survival abnormalities (Student’s t test; **P < 0.001, n = 7) and no significant rescue of retrograde survival relative to GFP+/FS+ infected TcKO neurons (Student’s t test; NS, P = 0.12). Expression of cytoplasm localized Elp1 (Elp1-cyto) completely rescued retrograde neuron survival (n = 4). For C, results were considered significant if the Bonferroni’s corrected P value was less than 0.013.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts